[1]
van de Sande, M. et al. 2021. Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial. Acta Orthopaedica. 92, 4 (May 2021), 493–499. DOI:https://doi.org/10.1080/17453674.2021.1922161.